140 related articles for article (PubMed ID: 7530069)
1. Drug eruption caused by recombinant human G-CSF.
Sasaki O; Yokoyama A; Uemura S; Fujino S; Inoue Y; Kohno N; Hiwada K
Intern Med; 1994 Oct; 33(10):641-3. PubMed ID: 7530069
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
Höglund M
Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685
[TBL] [Abstract][Full Text] [Related]
3. Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash.
McMullin MF; Finch MB
Clin Rheumatol; 1995 Mar; 14(2):204-8. PubMed ID: 7540527
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF).
Stanworth SJ; Bhavnani M; Chattopadhya C; Miller H; Swinson DR
QJM; 1998 Jan; 91(1):49-56. PubMed ID: 9519212
[TBL] [Abstract][Full Text] [Related]
5. Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Hüttmann A; Schirsafi K; Seeber S; Bojko P
J Cancer Res Clin Oncol; 2005 Mar; 131(3):152-6. PubMed ID: 15583936
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL).
Uozumi K; Nakahara K; Takatsuka Y; Ohno N; Makino T; Utsunomiya A; Hanada S; Arima T
Leuk Lymphoma; 1998 Apr; 29(3-4):407-14. PubMed ID: 9684938
[TBL] [Abstract][Full Text] [Related]
7. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
Shi YK; Zhou JC; Feng FY
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
[TBL] [Abstract][Full Text] [Related]
10. Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia.
Hirashima K; Yoshida Y; Asano S; Takaku F; Omine M; Furusawa S; Abe T; Abe T; Dohy H; Tajiri M
Biotherapy; 1991; 3(4):297-307. PubMed ID: 1723891
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous eruptions induced by granulocyte colony-stimulating factor in two cases of acute myelogenous leukemia.
Yamashita N; Natsuaki M; Morita H; Kitano Y; Sagami S
J Dermatol; 1993 Aug; 20(8):473-7. PubMed ID: 7504005
[TBL] [Abstract][Full Text] [Related]
12. [A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].
Xu B; Tian F; Yu J; Song Y; Shi J; Zhang B; Zhang Y; Yuan Z; Wu Q; Zhang Q; Nan K; Sun Q; Li W; Hu J; Bi J; Meng C; Dai H; Jiang H; Yue S; Cao B; Sun Y; Wang S; Tong Z; Shen P; Wu G; Tang L; Deng Y; Jia L; Shen K; Zhuang W; Xie X; Wu Y; Chen L
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):23-7. PubMed ID: 26796802
[TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
Gisselbrecht C; Haioun C; Lepage E; Bastion Y; Tilly H; Bosly A; Dupriez B; Marit G; Herbrecht R; Deconinck E; Marolleau JP; Yver A; Dabouz-Harrouche F; Coiffier B; Reyes F
Leuk Lymphoma; 1997 Apr; 25(3-4):289-300. PubMed ID: 9168439
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
Shi YK; Feng FY; Sun Y
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):739-42. PubMed ID: 7541325
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefits of lenograstim in patients with neutropenia due to chemotherapy for multiple myeloma (MM).
Takagi T; Sawamura M; Sezaki T; Kashimura M; Tsuchiya J; Hotta T; Ogawa N; Hirashima K
Support Care Cancer; 2001 Jul; 9(5):397-9. PubMed ID: 11497396
[TBL] [Abstract][Full Text] [Related]
16. Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Schippinger W; Holub R; Dandachi N; Bauernhofer T; Samonigg H
Oncology; 2006; 70(4):290-3. PubMed ID: 16899982
[TBL] [Abstract][Full Text] [Related]
17. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
18. Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer.
Soda H; Oka M; Fukuda M; Kinoshita A; Sakamoto A; Araki J; Fujino S; Itoh N; Watanabe K; Kanda T; Nakano M; Hara K
Cancer Chemother Pharmacol; 1996; 38(1):9-12. PubMed ID: 8603458
[TBL] [Abstract][Full Text] [Related]
19. Lichenoid cutaneous drug reaction at injection sites of granulocyte colony-stimulating factor (Filgrastim).
Viallard AM; Lavenue A; Balme B; Pincemaille B; Raudrant D; Thomas L
Dermatology; 1999; 198(3):301-3. PubMed ID: 10393459
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of lenograstim for prophylaxis of chemotherapy-induced neutropenia in patients with small cell lung cancer.
Drummond M; Davies L
Pharmacoeconomics; 1994; 6 Suppl 2():44-52. PubMed ID: 10155594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
